January 26, 2024
(press release)
–
Accrol (AIM: ACRL), the UK's leading independent tissue converter, will release its Half Year Results for the six months to 31 October 2023 on Tuesday 30 January 2024. As part of the Group's Results roadshow, the management will host an online investor presentation and Q&A session. This will take place on Friday, 2 February 2024 at 1.30pm. Anyone wishing to participate should register for the event with PI World at: https://bit.ly/ACRL_H124_results_webinar. For further information, please contact: Accrol Group Holdings plc Dan Wright, Executive Chairman Via Belvedere Communications Gareth Jenkins, Chief Executive Officer Chris Welsh, Chief Financial Officer Zeus (Nominated Adviser & Broker) Dan Bate / Jordan Warburton Tel: +44 (0) 161 831 1512 Dominic King Tel: +44 (0) 203 829 5000 Shore Capital Stockbrokers (Joint Broker) Tel: +44 (0) 20 7408 4090 Malachy McEntyre/ Mark Percy / James Thomas / Isobel Jones Belvedere Communications Limited Cat Valentine Tel: +44 (0) 7715 769 078 Keeley Clarke Tel: +44 (0) 7967 816 525 Overview of Accrol Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. For more information, please visit www.accrol.co.uk. Link for Accrol Today video: https://www.accrol.co.uk/our-business/ This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.
